Heterogeneity of DNA content in multiple synchronous hepatocellular carcinomas.

por Hui, A. M., Kawasaki, S., Imamura, H., Miyagawa, S., Ishii, K., Katsuyama, T., Makuuchi, M.
Publicado 1997

Reduced p21(WAF1/CIP1)protein expression is predominantly related to altered p53 in hepatocellular carcinomas

por Shi, Y-Z, Hui, A-M, Takayama, T, Li, X, Cui, X, Makuuchi, M
Publicado 2000

Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma

por Assouline, S E, Chang, J, Cheson, B D, Rifkin, R, Hamburg, S, Reyes, R, Hui, A-M, Yu, J, Gupta, N, Di Bacco, A, Shou, Y, Martin, P
Publicado 2014